Home session
 

Keywords :   


Tag: session

Work Session Schedule

2015-03-25 00:01:52| PortlandOnline

PDF Document, 7kbCategory: FY 2015-16 Spring Council Budget Work Session Materials

Tags: work session schedule work session

 

Portland City Council 03-18-15 PM Session

2015-03-19 23:52:02| PortlandOnline

Flash video

Tags: city session council portland

 
 

Portland City Council 03-18-15 AM Session

2015-03-19 23:51:42| PortlandOnline

Flash video

Tags: city session council portland

 

Portland City Council 03-17-15 Work Session

2015-03-19 23:01:53| PortlandOnline

Flash video

Tags: work city session council

 

New Data Investigating Mercks KEYTRUDA (pembrolizumab) in Advanced Non-Small Cell Lung Cancer and Mesothelioma to Be Presented in Clinical Trials Plenary Session at AACR 2015

2015-03-18 21:19:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. Data to be Presented Across Multiple Tumor Types for KEYTRUDA and MK-8628 (OTX015), an Investigational BET-Bromodomain Inhibitor KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data evaluating KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in both advanced non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma will be presented as part of the Clinical Trials Plenary Session on Sunday, April 19 at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia, April 18 22. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Claire Mulhearn, 908-236-1118orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: data advanced presented cell

 

Sites : [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] next »